Zdrowie i gospodarka · 14/08/2014

FDA Releases Final Guidance on Assessing Immunogenicity of Therapeutic Protein Products

The US Food and Drug Administration (FDA) has released a final guidance document to help pharmaceutical companies and clinical researchers evaluate the potential for therapeutic protein products to trigger immune responses, which could lead to serious side effects or reduced efficacy in patients.